Publicacións en colaboración con investigadores/as de IQVIA (10)

2023

  1. Clinical and economic hospital burden of acute respiratory infection (BARI) due to respiratory syncytial virus in Spanish children, 2015–2018

    BMC Infectious Diseases, Vol. 23, Núm. 1

  2. Excess hospitalizations and mortality associated with seasonal influenza in Spain, 2008–2018

    BMC Infectious Diseases, Vol. 23, Núm. 1

2022

  1. Clinical and economic burden of physician-diagnosed influenza in adults during the 2017/2018 epidemic season in Spain

    BMC Public Health, Vol. 22, Núm. 1

  2. Clinical and economic burden of respiratory syncytial virus in Spanish children: the BARI study

    BMC Infectious Diseases, Vol. 22, Núm. 1

2021

  1. Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

    Annals of Oncology, Vol. 32, Núm. 10, pp. 1245-1255

2020

  1. From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain

    PLoS ONE, Vol. 15, Núm. 5

2006

  1. Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life?

    European Journal of Endocrinology, Vol. 155, Núm. 1, pp. 109-119

  2. Impact of upper digestive symptoms in patients with irritable bowel syndrome

    European Journal of Gastroenterology and Hepatology, Vol. 18, Núm. 12, pp. 1271-1277

  3. Predictive factors of irritable bowel syndrome improvement: 1-Year prospective evaluation in 400 patients

    Alimentary Pharmacology and Therapeutics, Vol. 23, Núm. 6, pp. 815-826

2005

  1. Análisis de la relación coste-efectividad a corto y largo plazo de clopidogrel añadido a terapia estándar en pacientes con síndrome coronario agudo en España

    Revista Espanola de Cardiologia, Vol. 58, Núm. 12, pp. 1385-1395